4.58
-0.43%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhejiang Yatai Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 002370.SZ. It has been listed since 16 March 2010. In the fiscal year to 31 December 2025, it reported revenue of CN¥323.1m and net income of CN¥96.3m. At that date it held total assets of CN¥1.28bn and shareholders' equity of CN¥1.12bn.
Zhejiang Yatai Pharmaceutical Co., Ltd. engages in the research, manufacture & distribution of drugs. The company is headquartered in Shaoxing, Zhejiang. The company went IPO on 2010-03-16. The firm's main business consists of the research, development, production and sales of chemical agents, chemical raw materials and diagnostic reagents, as well as the provision of pharmaceutical research and development outsourcing (CRO) services. The Company’s chemical agents are classified as antibiotics and non-antibiotic drugs. Along with its subsidiaries, the Company provides preclinical research services, clinical research services and other advisory services. The firm distributes its products primarily in domestic markets and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 16 Mar 2010
- Employees
- 531
- Website
- ytyaoye.com ↗
Leadership
Pay as last reported
- Mr. Yaogen ChenChairman of the BoardCN¥73,389
- Mr. Cai FuVice Chairman of the Board, since 2022
- Zhen HeChief Financial Officer, Director, since 2010CN¥181,500
- Mr. Jianwei CenGeneral Manager, since 2024
- Yiyi ShenDeputy General Manager, Director, since 2011CN¥176,500
- Baokun HuDeputy General ManagerCN¥179,000
- Qinshui TanDeputy General Manager
- Liyun WangDeputy General Manager, since 2012CN¥181,495
- Mr. Wei HuangDirector
- Mr. Xiaoming HuangDirector, since 2022
- Mr. Yuehui LiuDirector
- Huabiao PingDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhejiang Yatai Pharmaceutical employs 531 full-time employees in Shaoxing, China.
- The company focuses on research, development, and production of chemical agents and diagnostic reagents.
- Zhejiang Yatai Pharmaceutical provides CRO services including preclinical and clinical research.
Weaknesses
- The company's main business is limited to chemical agents and diagnostic reagents.
- Zhejiang Yatai Pharmaceutical has no mention of international expansion plans.
- The firm's product range is restricted to antibiotics and non-antibiotic drugs.
Opportunities
- Zhejiang Yatai Pharmaceutical can expand into overseas markets for diagnostic reagents.
- The company can leverage CRO services to attract global pharmaceutical clients.
- Zhejiang Yatai Pharmaceutical may grow by developing new chemical raw materials.
Threats
- The domestic market dominance may limit growth opportunities for Zhejiang Yatai Pharmaceutical.
- Zhejiang Yatai Pharmaceutical faces competition from other Chinese pharmaceutical firms.
- The company's reliance on chemical agents could be affected by regulatory changes in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.